Telix Pharmaceuticals Targets U.S. IPO

Telix Pharmaceuticals Ltd. (AU:TLX) has released an update.

Telix Pharmaceuticals Limited has announced the initiation of its initial public offering (IPO) in the United States, with plans to raise $200 million by offering American Depositary Shares (ADSs) on the Nasdaq under the ticker symbol ‘TLX’. The company also intends to provide underwriters with an option to purchase additional ADSs, up to 15% more than the initial number offered. Renowned financial institutions such as Jefferies, Morgan Stanley, Truist Securities, and William Blair will manage the book-running for the IPO.

For further insights into AU:TLX stock, check out TipRanks’ Stock Analysis page.